No Compelling Evidence of Pancreatic Cancer Risk With GLP-1s ...Middle East

Medscape - News
Up to 7 years treatment with GLP-1 receptor agonist in patients with type 2 diabetes didn't seem to increase pancreatic cancer risk in a large population-based cohort study. Medscape Medical News

Hence then, the article about no compelling evidence of pancreatic cancer risk with glp 1s was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( No Compelling Evidence of Pancreatic Cancer Risk With GLP-1s )

Apple Storegoogle play

Last updated :

Also on site :



Latest News